Evidence map›Paper›PMID 17258067›Full record

ArticleExperimental hematology2007

Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Matin M Imanguli, Jane C Atkinson, Kristen E Harvey, Gerard T Hoehn, Ok Hee Ryu, Tianxia Wu, Albert Kingman, A John Barrett, Michael R Bishop, Richard W Childs and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Experimental hematology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2014
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Matin M ImanguliClinical Research Core, National Institutes of Health, Bethesda, MD 20892, USA.
Jane C Atkinson
Kristen E Harvey
Gerard T Hoehn
Ok Hee Ryu
Tianxia Wu
Albert Kingman
A John Barrett
Michael R Bishop
Richard W Childs
Daniel H Fowler
Steven Z Pavletic
Thomas C Hart
National Institutes of Health · USNational Institutes of Health Clinical Center · USNational Cancer Institute · USNational Heart Lung and Blood Institute · USCore Laboratories (United States) · USNational Institute of Dental and Craniofacial Research · US

Funding

GRAFT-VERSUS-LEUKEMIAZ01HL002342 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BARRETT, AUSTIN JOHN · 1994 to 2008
$7.7M
Allogeneic Immunotherapy for cancer and nonmalignant hematological disordersZ01HL002345 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHILDS, RICHARD · 2000 to 2008
$6.5M
Genetic Studies of Human Craniofacial DiseasesZ01DE000711 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI HART, THOMAS C · 2004 to 2008
$3.8M
Th1/Th2 &Tc1/Tc2 T Cell Subsets in Transplantation TherZ01SC010288 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI FOWLER, DANIEL · 1998 to 2008
$3.2M
Intramural NIH HHS Z99 DE999999
6 · The paper itself

Abstract

objectiveAllogeneic hematopoietic stem cell transplantation (allo-HCT) is frequently complicated by severe infections and graft-vs-host disease (GVHD). Saliva contains many components of adaptive and innate immune response crucial for local host defenses. Changes in salivary constituents could reflect systemic processes such as immune reconstitution and development of GVHD that occur posttransplant. This study was an initial evaluation of salivary protein changes that occur after allo-HCT. PATIENTS AND

methodsSerially collected saliva samples from 41 patients undergoing allo-HCT were evaluated. Changes in salivary proteome were initially examined by SELDI-TOF mass spectrometry. Individual protein changes were identified by 2-dimensional differential in-gel electrophoresis (2D-DIGE) with subsequent MS/MS sequencing and ELISA.

resultsSignificant increases and decreases in multiple salivary proteins that lasted at least 2 months posttransplant were detected by SELDI-TOF mass spectrometry. Lactoferrin and secretory leukocyte protease inhibitor demonstrated elevations 1 month post-HCT that persisted at least 6 months. Secretory IgA (sIgA) levels were decreased 1 month posttransplant, with recovery at approximately 6 months. Levels of salivary beta(2)-microglobulin were elevated at 6 months and correlated with sIgA levels.

conclusionAllo-HCT is associated with long-term changes in several salivary proteins important for innate immune responses. These results support further studies on the association of salivary proteins with posttransplant complications including infections and GVHD.

Indexed as

Adultbeta 2-MicroglobulinElectrophoresis, Gel, Two-DimensionalEnzyme-Linked Immunosorbent AssayFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansImmunoglobulin ALactoferrinMaleMultivariate AnalysisProteomeSalivaSalivary Proteins and PeptidesSecretory Leukocyte Peptidase Inhibitorbeta 2-MicroglobulinImmunoglobulin ALactoferrinProteomeSalivary Proteins and PeptidesSecretory Leukocyte Peptidase Inhibitor

Identifiers

PMID17258067
PMCPMC1832107
OpenAlexW1998905709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.